Source link : https://www.newshealth.biz/health-news/tamoxifen-reduces-risk-for-invasive-recurrence-of-dcis/
SAN ANTONIO — For patients with so-called “good-risk” ductal carcinoma in situ (DCIS) who did not have radiation therapy after breast-conserving surgery, adjuvant tamoxifen reduced their overall risks for invasive recurrence, but not their risks for recurrence in either the same or contralateral breast. These findings come from an exploratory analysis of combined data from […]
Author : News Health
Publish date : 2024-12-13 12:36:49
Copyright for syndicated content belongs to the linked Source.